Jaguar Health (JAGX) Other Accumulated Expenses (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Other Accumulated Expenses of $262000.0 for Q1 2026, up 2083.33% quarter-over-quarter from $12000.0 in Q4 2025.
Jaguar Health (JAGX) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Other Accumulated Expenses for 13 consecutive years, with $262000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $262000.0 (changed N/A YoY), while the FY2025 annual figure was $12000.0, down 7.69% from the prior year.
- Other Accumulated Expenses advanced to $262000.0 in Q1 2026 per JAGX's latest filing, from $12000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.0 million in Q4 2023 and bottomed at $9000.0 in Q4 2022.
- Historically, Other Accumulated Expenses has averaged $462600.0 across 5 years, with a median of $13000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 22311.11% — and 2024, when it slumped 99.36%.
- Jaguar Health's Other Accumulated Expenses stood at $9000.0 in 2022, then soared by 22311.11% to $2.0 million in 2023, then plunged by 99.36% to $13000.0 in 2024, then slipped by 7.69% to $12000.0 in 2025, then soared by 2083.33% to $262000.0 in 2026.
- Business Quant data shows JAGX's Other Accumulated Expenses at $262000.0 in Q1 2026, $12000.0 in Q4 2025, and $13000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Dec 31, 2020 | 978,000.00 |
| Dec 31, 2019 | 827,000.00 |
| Dec 31, 2018 | 2.08 Mn |
| Mar 31, 2018 | 329,948.00 |
| Dec 31, 2017 | 533,882.00 |
| Sep 30, 2017 | 366,017.00 |
| Jun 30, 2017 | 156,040.00 |
| Mar 31, 2017 | 14,921.00 |
| Dec 31, 2016 | 45,714.00 |
| Sep 30, 2016 | 12,870.00 |
| Jun 30, 2016 | 19,479.00 |
| Mar 31, 2016 | 23,485.00 |
| Dec 31, 2015 | 82,266.00 |
| Sep 30, 2015 | 216,292.00 |